If your electronic medical device exchanges data with other devices, you need to read the new draft guidance just published by the FDA.  This document contains recommendations intended to promote the safe and effective exchange of information between devices.  Make sure you and your team are aware of these best practices, so you can incorporate them into your medical device.

What’s in this draft guidance document?

Within this guidance, “interoperability” is defined as the ability of two or more products, technologies or systems to exchange information and to use the information that has been exchanged.

Design Considerations

These specific development and design considerations should be taken into account:

  • Technology to support the purpose for the data interface (e.g., send-only, receive-only, control)
  • The expertise and limitations of expected users
  • Risk identification, assessment, and mitigation
  • Validation and verification to ensure that the devise is working correctly before delivery and continues to work in real use
  • Labeling to ensure safe, predictable use

Download the FDA draft guidance here: Design Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices

Do you need more help implementing these recommendations within your organization? Talk to our CSV experts to see how they can help.

Like it? Share it:

You may also like

Are you complying with the new FDA General Wellness Policy for Low Risk Devices?
19 August, 2016

In July 2016, the FDA released Guidance for Industry and FDA Staff – General Wellness: Policy for Low-Risk Devices to cl...

How Are You Managing Your Postmarket Cybersecurity Vulnerabilities For Medical Devices?
5 January, 2017

At the end of 2016, the FDA published Guidance for Industry and FDA Staff, Postmarket Management of Cybersecurity in Med...

Warning Letter Roundup - December 2016
19 December, 2016

The FDA sends Warning Letters and 483s to companies that significantly violate FDA regulations. We gather those related ...